Speak up, share the news, make knowledge ready…
…for treatments, rehabilitation, health management and prevention.
Become a speaker and enjoy free traveling and hosting at the conference. Experts and stakeholders are invited to apply as speakers.
Dr. Kronbichler is doctor of internal medicine at the Medical University of Innsbruck. His research focuses on autoimmune kidney diseases (systemic and localized) and acute kidney injury (AKI), especially contrast-associated AKI. During a PhD program, a microbiome study was conducted at the University of Cambridge, aiming to characterize the nasal microbiome of patients with granulomatosis with polyangiitis (GPA, Wegener’s).
He is speaking about: "The Nasal Microbiome and its Impact for Therapy and Prevention" in Workshop H
We have identified carriage of Staphylococcus pseudintermedius in a proportion of patients and healthy controls, which has been assumed to be a dog-bound pathogen. The nasal microbiome is of particular interest to understand GPA, since about 90% of patients present with an initial involvement of the ear, nose and throat (ENT) tract. Further research in the field is on its way to further decipher the complex interplay between microbes and disease. There is an interest in the treatment of these disease with alternative measures, especially targeted antibiotics. Dr. Kronbichler has published over 70 articles in peer-reviewed journals and is current member of national and international societies (including the ERA-EDTA, the German and Austrian Society of Nephrology).
Derek is director of the BiaNomics Business Unit at BaseClear which focuses on the industrial applications of microbial genomic analysis. In 2001 he received a PhD from the university of Cork for his work on the genetic regulation of lactic acid bacteria. In 2015 he completed an executive MBA at TIAS Business school. He has more than 16 years’ experience in the biotechnology industry focusing on microbiology and genomics and is currently part of the BaseClear management team.
He speaks about: The Microbiota of Our Skin and it’s Analysis. In Workshop H.
Dr. Ralf Doyscher is a German medical doctor, specialist for orthopedics and trauma surgery and specialized in non-surgical sports medicine. He is working as a full time team doctor with the German first league soccer club „Borussia VFL 1900 Mönchengladbach“ as well as a guest-scientist with the department for sports medicine at the Charité – Universitätsmedizin Berlin.
He will share his experience about: "New Insights into the Genomic Mode of Action of Low-Dose-Phytopharmaca in Sports injuries"in Workshop E
Clinical Focus and Professional Baclground:
Ralf owns a specialization in diagnostics, treatment and prevention of muscle injuries, as well as the non-surgical treatment of cartilage defects of the athlete´s joint. One of his main focus is musculoskeletal sonography as well as ultrasound-guided injection-techniques. After his medical studies in Germany, South Africa and the USA Ralf successfully passed the German as well as the US federal licensing examinations.
He completed his training in orthopedic and trauma surgery at the Centre for Musculoskeletal Surgery (CMSC) at Charité Berlin. He was responsible for the development of the orthopedic part of the Sports Medicine Department at the same hospital. Therefor he also worked as team doctor of 1. FC Union Berlin, Füchse Berlin as well as for the German Bobsleigh and Sled Federation (BSD) and the German Athletics Association (DLV).
Dr. van der Lelie earned his Ph.D. in Mathematics and Sciences from the University of Groningen, The Netherlands, in 1989. After a Postdoctoral position at Transgène, Strasbourg, France, he worked for 11 years as a Research Scientist at the Belgium Nuclear Research Centre (SCK-CEN) and the Flemish Institute for Technological Research (VITO). In August 2001, he joined the Biology Department of Brookhaven National Laboratory (BNL) and in January 2011, he joined RTI International where he successfully founded the Center for Agricultural and Environmental Biotechnology (CAEB).
He speaks about: “The Microbiome and Virome Interactions in Oncology and Immunology: Current Knowledge and Concepts and Future Challenges“ At morning session 1.6.:click on presentation title.
In addition, he became the Acting Director of the Center for Microbial Communities & Health Research. In 2013, CAEB was acquired by FMC Corporation to become the cornerstone of their global R&D engine to develop sustainable agricultural biosolutions based on plant associated microorganisms. In 2015, Dr. van der Lelie was one of the co-founders of Gusto Global, a startup that aims to develop microbiome-based therapeutics for immune modulation. Gusto was created around the vision that state of the art bioinformatics and modeling can be successfully used to improve and lower the costs of the R&D process, including strain characterization and product optimization, patient stratification, clinical trials and regulatory acceptance for microbiome-based therapeutics. Since becoming the CSO in July 2016, he has played a critical role in defining Gusto’s strategic vision, and to translate this into an action plan that is successfully being implemented to develop Gusto’s core facilities and technology platforms, create strategic partnerships with academic and commercial entities (e.g. around preclinical trials), define and license technologies, build an IP portfolio, and to obtain startup funding from VC and strategic investors.
His research has resulted in more than 150 publications in peer reviewed journals and over 20 patents / patent applications.
Mikael works in the crossroads between academic research, sports performance, and implementation of technologies in health care and exercise. He received his Master's degree in physiology (2006) and his Ph.D. in Medical Science - physiology (2011) from Karolinska Institutet in Sweden. He did his thesis on the physiology of ultra-endurance athletes (Adventure Racers). From 2011 to 2018 he held a position as assistant professor in the department of Professors P-O. Åstrand and B. Ekblom at The Swedish School of Sport and Health Sciences, Stockholm, Sweden. Since 2012 he holds a research position at Stanford University, where he leads the research project "ELITE: Exercise at the Limit - Inherited Traits of Endurance" about the genetic profiles of the best endurance athletes in the world.
His presentation is in Workshop A: "Personalized Preventive Medicine: Genetics and the Response to Exercise"
He has written numerous research articles as well as four books about exercise, training, and sports performance, and is often hired speaker and expert in Digital Health, with special knowledge in Precision Health, Exercise Physiology, Endurance Training, Exercise and the Heart, Sports Genetics, Mobile Health, and Exercise Analytics.
Nowadays he's also a senior researcher at RISE (Research Institutes of Sweden) and the CEO of Silicon Valley Exercise Analytics.
Sylvia Duncan has a PhD in Microbiology and is a Research Scientist at the Rowett Institute, Gut Health group, University of Aberdeen, Scotland, UK. She has published over 120 peer reviewed papers on microbial ecology and nutritional consequences of dietary polymer fermentation in the gut.
Her research interests include anaerobic microbiology and metabolite profiling of gut microbial communities, including studies on controlled human dietary intervention studies. This has provided unique information on the dynamics of the gut microbiota and provided information on inter-individual colonic microbial variability and the responsiveness of the gut microbiota to dietary shifts.
She speaks about: "The impact of diet, pre- and pro-biotic strategies on gut microbiota composition and healthy aging" Workshop B
She has also isolated and characterised some of the key bacterial species from the human colon that degrade prebiotics and complex fibres and detailed studies on these isolates has led to the identity of which species make a major contribution to the synthesis of the major short chain fatty acids, acetate, propionate and butyrate. Her work also includes studies on species that convert lactic acid into butyrate. Moreover, studies have also been conducted on the bacterial species that play a role on the release and transformation of the plant phenolics that may have important health consequences.
Shivani lived in Japan for advanced studies and work for 13 years. Deeply interested in the Japanese society and how it is coping with an aged population, with specific interest regarding people with dementia. She has a Ph.D in Japanese studies from Graduate Univ for Advanced Studies in Kyoto. Worked as medical writer for Eisai Pharmaceutical Company and a medical communications company in Tokyo.
Shivani will speak about: "Japanese Approaches to Healthy Ageing and Innovative Dementia Care Models."
Represented the Japanese Alzheimer Association at the ADI (Alzheimer Disease International Conference) for several years as well as volunteered at a local long term care nursing home in Kyoto for many years. M.Phil in Chemistry and Advanced Diploma in Japanese language from Delhi University. Currently a freelance professional Japanese translator/interpreter in the US. Also served for two years as a Volunteer Long Term Care Ombudsman at a nursing home in the US.
Florian studies Public Health for his Masters (Msc) at the Ludwig-Maximilian-University in Munich. In the past he worked for the Hochschule München as a researcher and scientist. Since his Bachelor´s degree in Nursing science (BscN) was a practical oriented vocational training, he had the opportunity to work within different parts of the German health care system, most recently at a psychiatric hospital. He gained experience in international health and social care systems during international courses and volunteer work in Europe, Central America and Asia.
In the colloqium workshop- scientist meet students- he speaks about „A Day Course in the Future Life of Homo Sapiens Microbiomicus”
Besides health care and prevention Florian is particularly interested in development assistance and statistical analysis. Besides working in research and the health care system he also organizes health courses like the CGEpi Winterschool where he first got experience about strategies for personalized medicine.
You can find Florian Holzmüller on Linked in.
Moritz Hagenmeyer has been a lawyer in Germany since 1994, a barrister (England and Wales) since 1995 and has been practising with KROHN Rechtsanwälte in Hamburg since 1998. He works primarily in food and unfair competition law. He is also a lecturer in food law at the Hamburg School of Food Science and Leibniz University Hanover, a member of the BLL Legal Committee and Germany Correspondent of EffL.
He will explain us the thrilling current legal situation of the probiotics in the health markets: Probiotics and the microbiome: Legal framework and challenges
Furthermore, he is also Chairman of the DCB Sports Tribunal and a CAMRA Life Member. He is well known in the food sector through numerous publications as well as presentations at events in Germany and abroad. Clients, competitors and seminar participants value his services as fast, imaginative and entertaining.
KROHN Rechtsanwälte has a long tradition as a business-oriented law firm located at the shore of Hamburg's Alster lake and with another office in Germany's capital Berlin. The law firm Krohn & v. Jagow was among the first German law firms that specialised in advising the food sector.
Paula is a public health master student in Munich. During the last years, she collected a lot of experience while working in and with renowned and leading health and medical service providers like the pharmaceutical company Lilly Deutschland GmbH in Frankfurt. She also worked in different hospitals and got insights into the primary care while working in a doctor's office.
In the colloquium workshop - scientists meet students, session 2 - she presents innovative and provoking ideas about „The Health and Recovery Management of Tomorrow: A Future Day Course in the Life of a Rehabilitation Patient “
Furthermore she cooperated with some large companies like De´Longhi to elaborate a mental risk assessment for the employee health management. In addition she is a research assistant at the public health department in Munich. Accordingly of her various work experiences and her studies, she was able to gain a comprehensive overview from different perspectives of the German health system. Her strong interest is in the improvements of the health care, especially in the fields of prevention and rehabilitation. How can you keep people healthy or integrate them into their everyday lives as soon as possible after illness?
You can find Paula Schwenke on LinkedIn.
Owner Orenda Real Estate Group - Bigger Health Vision Provider
He founded and built the Psychosomatic Medicine Museum in Jacksonhole/Yenqing, China. Founder of the Boai Charity Fund; Chairman of the Board of Directors of the Joy International Holdings Group; Vice president of Yanhuang Culture Research Association; Ambassador of the Chinese Tai Chi Culture; Practitioner, ambassador and operator of the Psychosomatic Health Model.
His vision are urbanizations in China and internationally which are organized and serviced in a way that health is supported from all angles of daily life without being intrusive or pestering peoples life, but diligently supporting the idea of prevention and health management. As he is a Tai Chi Master its a great opportunity to have a holistic learning about Tai Chi with him in person. A unique opportunity and the first time outside of China!
Visit his session on DAY 1 afternoon.
The Orenda Group supports this conference. It is owed to their cosmopolitan understanding of health. Medicine and patients do not have borders. Liu Xiangyang will be present on the event and AIRS will take care of networking on request with him. A special interest is precision and personalized medicine and investing opportunities to build "Healthy Ageing Villages" outside of China. In this relation Orenda and AIRS have a mutual interest and collaboration to omplment healthy living standards for an ageing world. Realization partners welcomed.
Dr. Roosmarijn Vandenbroucke is Associate Professor in the Department of Biomedical Molecular Biology at Ghent University and Groupleader at the Center for Inflammation Research at VIB in Belgium. She obtained her PhD in Pharmaceutical Sciences in 2008 entitled ‘Non-viral delivery strategies to guide therapeutic nucleic acids through cellular barriers’.
From a scientific basec viewpoint ashe presents about: "Hype or reality: does our gut control our mind?"
Since end 2015, she heads the 'Barriers in Inflammation' research team that studies two barriers that play an important role in a broad range of inflammatory disorders, namely the gut and brain barriers. She is spokesperson of the UGent multi-disciplinary consortium 'The Inflammatory Gut-Brain Axis' that groups almost 20 research groups at Ghent University and aims at desciphering the impact of gastrointestinal inflammation on brain health. In 2017, she obtained the prestigious 'Baillet Latour award' that is granted yearly to a promising young Belgian researcher.
Daphna Rothschild is a PhD student in the Weizmann Institute of Science focused on advancing the field of biomedical research with specific role in advancing bacterial treatment in disease. Though analytical analysis and developing a state of the art tools to measure microbiome effect on human traits, Daphna studies the relation between the gut microbiota and human health.
She speaks about: "Environment dominates over host genetics in shaping human gut microbiota"
She works at the WEIZMANN INSTITUTE OF SCIENCE (2007 – uptodate) in Rehovot, Israel. PhD. Computer Science and Applied Mathematics, MSc. Biology track, Thesis: Linear superposition and prediction of bacterial promoter activity dynamics in complex conditions
Blacher E, Bashiardes S, Rothschild D, Mor U,Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, Zabari M , Ben-Zeev Brik R, Zmora N, Bar N, Levi I, Amar N, Mehlman T, Brandis A , Biton I, Kuperman Y, Tsoory M, Shenta N, Harmelin A, Shapiro H , Schwarz M, Gotkine M, Segal E, Elinav E. Potential role of distinct gut microbiome commensals & associated metabolites in modulation of Amyotrophic Lateral Sclerosis (revision in Nature).
Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Zmora N, Zilberman-Schapira G, Suez J, Mor U, DoriBachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik RB, Federici S, Cohen Y, Linevsky R, Rothschild D, Moor AE, Ben-Moshe S, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Shapiro H, Pevsner-Fischer M, Sharon I, Halpern Z, Segal E, Elinav E. Cell. 2018 Sep 6;174(6):1388-1405.e21. doi: 10.1016/j.cell.2018.08.041.
Weissbrod O, Rothschild D, Barkan E, Segal E. Host genetics and microbiome associations through the lens of genome wide association studies. Current opinion in microbiology. 2018 Aug 31;44:9-19.
Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, Shilo S. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018 Mar;555(7695):210.
Thaiss CA, Itav S, Rothschild D, Meijer MT, Levy M, Moresi C, Dohnalová L, Braverman S, Rozin S, Malitsky S, Dori-Bachash M. Persistent microbiome alterations modulate the rate of postdieting weight regain. Nature. 2016 Dec;540(7634):544.
Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M, Suez J, Mahdi JA, Matot E, Malka G, Kosower N, Rein M, Zilberman-Schapira G, Dohnalová L, Pevsner-Fischer M, Bikovsky R, Halpern Z, Elinav E, Segal E. Personalized Nutrition by Prediction of Glycemic Responses. Cell 2015.
- Rothschild, E. Dekel, J. Hausser, A. Bren, G. Aidelberg , P. Szekely, U. Alon. Linear superposition and prediction of bacterial promoter activity dynamics in complex conditions (PLoS Computational Biology 2014).
- Aidelberg, B. Towbin, E. Dekel, A. Bren, D. Rothschild, A. Tendler, U. Alon. ierarchy of nonglucose sugars in Escherichia coli (BMC Systems Biology 2014).
Poster: D. Rothschild, E. Dekel, J. Hausser, A. Bren, G. Aidelberg, P. Szekely, U. Alon. Dynamics of bacterial promoter activity in a combination of conditions: a weighted average of the dynamics in each condition alone (Heidelberg, Germany, 2013).
AWARDS AND SCHOLARSHIPS: Women in science - Weizmann Institute of Science Scholarship (2018)
Women in science - Séphora Berrebi Scholarship (2017)
Eshkol fellowship for personalized medicine (2016)
Dean Prize for MSc Students (2014)
Azrieli Systems Biology Prize (2014)
CONFERENCE PRESENTATIONS: Oral presentation delivered at the IHMC International Human Microbiome Congress (Killarney Ireland, 2018) Oral presentation delivered at the genetics, genomics & evolution students conference (Ramat Gan, Israel, 2017) Poster presentation at Promoting technological innovations in engineering science (Haifa, Israel, 2017) Oral presentation delivered at the Unified Forces – Preventive Nutrition conference (Tel Aviv, Israel, 2017) Oral presentation delivered at the Federation of Israel Societies for Experimental Biology – Ilanit (Eilat, Israel, 2017) Poster presentation at New Approaches and Concepts in microbiology (Heidelberg, Germany, 2013)
RESEARCH INTERESTS: Metagenomics and Microbiome Regulatory Genomics and Cellular Decision making principles Epigenetics, Chromatin and Nuclear Dynamics Constraints on Exponential growth
Prof. Dr. Koen Venema is i) founder and CEO of the company Beneficial Microbes Consultancy, ii) the initiator and co-organizer of the Beneficial Microbe Conference-series, iii) editor-in-chief of Beneficial Microbes, and iv) Professor at University Maastricht - campus Venlo, where has a chair in Gut Microbiology.
He has two speakging slots (main session and workshop):
The gut microbiota has been shown to be extremely important in health and disease. In his group the effect of food components on health and disease through the gut microbiota are studied using the sophisticated TNO in vitro models of the gastrointestinal tract (nick-named TIM), with which he has 20 years of experience. His research focuses on on means to modify the composition, but especially the activity/functionality of the gut microbiota in relation to health and disease.
Secretary General of Sport and Rehabilitation Industry Branch (SRIB) of CAHPE. Vice Director of Hospital Management Research Institute of Economic Research Center, Chinese Academy of Social Sciences. EMBA in Peking University, Beijing, China
Dr. Zhao presents in cooperation with AIRS (publisher) the concept of the international Handbook edition for China: "Handbook of Genomics and Microbiomics for the NEW Rehabilitation".
AIRS develops with international leading authors a guideline and handbook for the use of genomics and microbiomics research results in the rehabilitation and sports medicine context. Applicants for contributions still welcome.
Professor of Economics in National School of Development at Peking University, Director of Health Development Studies Center in Peking University, member of Expert Advisory Committee for Deepening Medical System Reform in State Council, Expert and Consultant to Chinese Medical Reform in World Bank, Core Expert in the Health China 2030 Guidelines.
Prof. Ling summarizes about: "Integration of Genomics and Microbiomics into Public Health Programs"
Due to her key role and position in China´s Public Health Concept her lecture is a must for all who are interested in health developments in China.
Ms. Margit Schlenk is CEO Moritz Apotheke Nuremberg, NM VITAL Apotheke Neuwmarkt, Author and Speaker
Lecturer for the Bayerische Landesapothekerkammer and other Pharmacist Associations, FAU Erlangen Nürnberg, Uni Basel and some Chambers of Industry and Commerce (IHK)
She will look at: "Microbiotica: Market Developments and Customer Feedback: Viewpoint of a Large Pharmacy"
GENERAL HIGHER ENTRANCE QUALIFICATION 28.06.1985
Pharmacy Course 1985-1989 FAU Erlangen Nürnberg
Licence to practice as Pharmacist 31.07.1990
Research Assistant in Pharmaceutical Technology 7/1990- 9/1990
Pharmacist in Marien Apotheke Schnaittach -1999
Establishing/Foundation MoritzApotheke Nürnberg 1.9.1999
Establishing/Foundation NM Vital Apotheke im Ärztehaus 01.04.2009
1992 - 1999 Lectureship "staatlich anerkannte Fachschule für Altenpflege und Altenpflegehilfe Neunkirchen/Sand" in Application of Medicines in Elderly
Until now Consultant for Health Matters in Phytopharmacy, Polypharmacy, Microbiomics, Gender Pharmacy
Tutor for the "ATHINA" Projekt: Management of Polypharmacy
Teacher for the "Bayerische Landesapothekerkammer" and others for Nutritional Science, Phytopharmacy, Prevention of Diseases
Co-Author in several Books ( Complementary Pharmacy, Aromatherapy, Phytopharmacy)
Exam Committee Member for several Further Trainings of the Bayerische Landesapothekerkammer
Medikationsmanager BaklinPharma, Präventionsmanager WIPIG
Prof. Dr. med. Jörg Spitz from Schlangenbad near Wiesbaden is a medical specialist for nuclear medicine, nutrition medicine and preventional medicine. After acquiring his state doctorate he was engaged among other positions as Head of Nuclear Medicine at the Municipal Hospital Wiesbaden and as Professor for Nuclear Medicine at the University of Mainz.
In 2009 he established the German non-profit Foundation for Health Information and Prevention (DSGIP). In 2011/2013 he organized on a federal level a congress regarding the role of vitamine D. Since 2014 he has been organizing the annual “Congress for Humane Medicine” the University of Frankfurt.
In 2014 he founded the AMM GmbH (Academy for Humane Medicine and High End Prevention – www.spitzen-praevention.de), serving as an umbrella organization for the implementation of advanced and professional prevention concepts.
In 2015 he received a call to become the president of the society for biologic cancer defense (GfbK) in Heidelberg. The amplification of the systemic AMM-Concept for “Peak Health” was achieved in 2016 for the provision of prevention and therapy of diseases supposed to be untreatable up to date.
Examples of his extensive lecture activities can be seen at youTube as well:
Deanna Utroske, Editor of Cosmetics Design
Deanna Utroske covers daily beauty business news in the Americas region for the online industry publication Cosmetics Design and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.
Her writing follows the evolution of cosmetics and personal care industry trends and movements, including green and clean beauty, marine ingredients, the intersection of beauty and wellness, the global independent beauty movement, beauty tech, consumer genomics, as well as research, ingredients, and brands focusing on the skin microbiome.
Based in New York City, Deanna is a globally sought-after speaker and industry commentator, sharing insights with market research firms and consumer beauty magazines, and speaking on industry podcasts and at cosmetics, personal care, and packaging events around the world.
Corinne Benakis, PhD, Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany
Corinne Benakis is originally from Switzerland where she studied biochemistry before obtaining a PhD from the Lemanic Neuroscience program at the University of Lausanne under the mentorship of Prof. Lorenz Hirt.
Her PhD thesis focuses on the anti-inflammatory properties of a neuroprotective compound in cerebral ischemia, notably on the role of microglia. She then joined the laboratory of Prof. Costantino Iadecola at Weill Cornell Medical College in New York as a postdoctoral researcher with a fellowship from the Swiss National Research Foundation, where she investigated the interaction of the gut microbiota with the intestinal immune cells in stroke.
These novel findings–linking the brain neuroinflammation and the gut microbiota–were published in Nature Medicine in 2016. She then joined the laboratory of Dr. Arthur Liesz in Munich, Germany, at the Institute of Stroke and Dementia, with a Marie Curie grant from the European Commission to develop her own research topic on the specific role of gut metabolites on immune cell polarization in the context of brain injury.
Jörg Blech is the Berlin-based science correspondent for Der Spiegel, Germany largest weekly news magazine. He studied molecular biology and biochemistry at the University of Cologne and at the University of Sussex. His best-selling books have together been published in a dozen languages. In 2000, Jörg Blech published the first book on the human microbiome and about all the creatures that live in our body. The book was updated in many printings and became a classic. Ever since Jörg Blech reports on microbiome research and its implication for our microbial self.
J. Blech speaks about: The Microbiome Story for Advancing Health: Perspectives on Roots and Realization
Blech is book author of the microbiome literature high seller: "Leben auf dem Menschen" (Living on man).
See also his blog on this website: https://airs-conference.net/index.php/en/blog-airs-conference
Gregory A. Buck, Ph.D., is Professor of Microbiology and Immunology and Computer Science and Director of the Center for Microbiome Engineering and Data Analysis at Virginia Commonwealth University.
His presentation: "The Impact of the Vaginome on Health Management of the Reproductive Tract, Pregnancy, Newborns and Interactions with Other Human Microbiomes: Opportunities for New Hygiene and Clinical Support Products"
He obtained a BS in Genetics from the University of Wisconsin-Madison, and his MS and Ph.D. in Microbiology and Immunology from the University of Washington-Seattle studying the toxinogenic bacteriophages of Corynebacterium diphtheria. He did postdoctoral research at the Institut Pasteur in Paris studying the genetics of antigenic variation in African Trypanosomes, and subsequently joined the faculty in the department of Microbiology and Immunology at VCU. He founded VCU’s Nucleic Acids Research Facilities which maintains VCU’s Next Generation Sequencing infrastructure, and Center for High Performance Computing which provides research computing capacity to VCU’s investigators. He founded the Center for Microbiome Engineering and Data Analysis at VCU in 2018. Dr. Buck’s recent work has focused on high throughput microbial genomics and metagenomics, with a focus on evaluating the impact of the vaginal microbiome on women’s health and pregnancy.
Bonnie Feldman, DDS, MBA, (DrBonnie360) is the founder of Your Autoimmunity Connection. Bonnie and her team consult with companies and entrepreneurs developing new products and services to improve all aspects of chronic care. As a thought leader and champion for the 50+ million with autoimmune diseases, she uses her quadruple lens - of a healthcare provider, researcher, scientist and patient - to create a digitally connected world of personalized care for autoimmune patients.
In the past two years alone, Bonnie has been an invited speaker at conferences including TEDx and SXSW, interviewed 250+ start-up companies, and attended 70+ digital health meetings. Bonnie’s mission is to reshape research, diagnosis, and treatment of all autoimmune diseases, as well as empower patients with the tools, coaching, and community to achieve their healthiest self. She welcomes collaborative partners in these initiatives at www.drbonnie360.com. People interested in her oral microbiome e-book are welcomed to get in touch with her.
University of Louisville School of Medicine
Robert Paul Friedland (BS, City College of New York 1969; MD, Mount Sinai School of Medicine, New York, 1973) completed a fellowship in brain aging and dementia at the Albert Einstein College of Medicine in New York and worked as Chief Neurologist at the Donner Laboratory, University of California Berkeley. At the National Institute on Aging, NIH he served as Deputy Clinical Director and Chief of the Brain Aging and Dementia Section.
Prof. Friedland speaks about: "The role of the microbiota in brain aging and the potential for gene therapy"
Dr Friedland moved to Cleveland in 1990 to be Professor of Neurology, Radiology and Psychiatry at Case Western Reserve University School of Medicine. In 2008 he came to the University of Louisville and became Chairman and Professor of Neurology & Anatomical Sciences and Neurobiology, and the Rudd Chair. He also served as Interim Chair of the Dept. of Neurosurgery and is currently Chief of the Laboratory of Neurogeriatrics at the University of Louisville.
Dr. Friedland’s work has focused on multidisciplinary approaches to neurodegenerative diseases in an effort to: 1) uncover the environmental factors responsible for their development; and 2) develop effective preventive and therapeutic measures. His work has involved studies in the Middle East, Africa and Japan, as well as the USA. Dr. Friedland has authored or coauthored over 220 scientific publications in refereed journals, and his work has been cited over 12,000 times. His current approach to the mechanisms of initiation of neurodegeneration developed from a longstanding interest in the biology of brain aging. Recent research from his lab is focused on human subjects as well as animal models of Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis and frontotemporal lobar degeneration (Pick’s disease). His collaborators include faculty at the University of Louisville in the Departments of Neurology, Anatomical Sciences and Neurobiology, Biochemistry, Oral Immunology, Physiology, Epidemiology and Biostatistics, and the Cancer Center. Research is also underway with colleagues in Ireland, The United Kingdom and Japan. In 2017 he was appointed Visiting Professor at the Shiga University of Medical Sciences in Otsu, Japan. Dr. Friedland sees patients with a focus on cognitive, behavioral, and geriatric neurology.
Dr Sofia Forslund trained as a molecular biotechnologist in Uppsala, then aquired a PhD in computational biology in Stockholm. After post-doc at the EMBL she founded the Host-microbiome systems medicine of cardiometabolic disease group at the ECRC (MDC/Charité) in Berlin.
Dr. Forslund speaks about: "The gut microbiome in disease progression and treatment"
Sofia focuses on 1) evolutionary and systems bioinformatics tool development, confounder analysis and big data integration, 2) metagenome analyses of pathogenicity of microbiomes including antibiotic resistance, and 3) roles of microbiota in rise, treatment, diagnosis and management of systemic disease or health of the host. Twitter: @forslund_lab, @inanna_nalytica ; website: https://www.mdc-berlin.de/forslund .
Dr. Jane Foster is an Associate Professor in the Department of Psychiatry and Behavioural Neurosciences at McMaster University in Hamilton, ON. Dr. Foster is an active researcher in two large translational networks - the Province of Ontario Neurodevelopmental Disorders Network (POND) and the Canadian Biomarkers in Depression (CAN-BIND).
She will cover the state of the art for: "The Influencing Factors of the Microbiome and Genomics with Outcomes for Psychologic and Psychiatric Conditions"
In addition Jane will conduct a workshop where we work on The benefits of academic-industry partnerships in relation with microbiomics - which is mega-important and mega-interesting for both players.
By combining basic science research with clinical collaboration in psychiatry, psychology, and gastroenterology, the Foster lab has developed a ‘bench to bedside’ and back again approach to studying microbiota-brain and immune-brain systems aimed at understanding how these relationships contribute to psychiatric disorders such as neurodevelopmental disorders, anxiety and depression.
Professor Jack A Gilbert earned his Ph.D. from Unilever and Nottingham University, UK in 2002, and received his postdoctoral training at Queens University, Canada. From 2005-2010 he was a senior scientist at Plymouth Marine Laboratory, UK; and from 2010-2018 he was a Professor of Surgery and Director of The Microbiome Center at University of Chicago. In 2019 he moved to University of California San Diego, where he is a Professor in Pediatrics and the Scripps Institution of Oceanography.
He will cover an overall important topic in microbiomics: "The individual and inter-individual microbiome transfer routes and their impact for treatments, recovery and prevention"
He is also Group Leader for Microbial Ecology at Argonne National Laboratory, and the Yeoh Ghim Seng Visiting Professorship in Surgery at the National University of Singapore. Dr. Gilbert uses molecular analysis to test fundamental hypotheses in microbial ecology. He cofounded the Earth Microbiome Project and American Gut Project. He has authored more than 250 peer reviewed publications and book chapters on microbial ecology. He is the founding Editor in Chief of mSystems journal. In 2014 he was recognized on Crain’s Business Chicago’s 40 Under 40 List, and in 2015 he was listed as one of the 50 most influential scientists by Business Insider, and in the Brilliant Ten by Popular Scientist. In 2016 he won the Altemeier Prize from the Surgical Infection Society, and the WH Pierce Prize from the Society for Applied Microbiology for research excellence. He also co-authored “Dirt is Good” published in 2017, a popular science guide to the microbiome and children’s health.
Dr. Isaksen earned his doctorate in Biotechnology from the University of Oslo in 1993. As part of his doctorate, he was visiting scholar at UC Berkeley from 1990 – 1991, and at The European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany in the fall of 1991.
Dr. Isaksen will present about: "Precision microbiome-adjusted nutrition for personalized medicine: state of the art and procedures."
He has since had extensive experience with commercial biotech; established and run several biotech companies in Norway and the UK, and has acted as consultant for many others. Most recently, he set up and was the CEO of the gut microbiome company Genetic Analysis from 2008 to 2013. He is the Founder and CEO of Bio-Me, which was established in 2016.
Dr. Jianan Li is an international associate of the National Academy of Medicine, USA. He is professor and Dean of the College of Rehabilitation Medicine in Nanjing Medical University, as well as Chairman of Medical Rehabilitation Center of its First Affiliated Hospital, and president of the Zhongshan Rehabilitation Hospital, China.
Prof. Li Jianan will speak about: "The NEW Rehabilitation Based on Genomics and Microbiomics"
He is the immediate past-president of International Society of Physical and Rehabilitation Medicine (ISPRM) and the International Member of National Academy of Medicine, USA. His main field is in Spinal cord injury rehabilitation, Cardiac rehabilitation and Motion analysis and motor control.
Prof. Dr. Eckhard Schoenau is medical director of the UniReha GmbH and consultant at the Children’s Hospital University of Cologne, Germany responsible for the management of the polyclinic for general pediatrics since 1991.
His contribution is about: "The Role of the Microbiome for the Treatment of Rare Neurodegenerative Children Diseases."
He graduated from medical school in Erlangen, Germany in 1986 followed by specialist training for pediatric and adolescent medicine at the Department of Pediatrics at the University of Luebeck, Germany.
In 1999 he was appointed Professor at the University of Cologne. On the basis of extensive research in the area of musculoskeletal diseases, Prof. Schoenau established the Rehabilitation Center "Queen Rania Rehabilitation Center" for children and adolescents with reduced mobility "Auf die Beine" at the University Hospital Cologne, Germany in 2006 and is medical director since then.
The management of the Center for Prevention and Rehabilitation, UniReha GmbH (100% subsidiary of the University Hospital of Cologne) followed in 2008. He has presented her research nationally and internationally (161 original papers, 57 reviews, 51 book chapters).
Taylor C. Wallace, PhD, CFS, FACN, is Principal and CEO at the Think Healthy Group and an Adjunct Professor in the Department of Nutrition and Food Studies at George Mason University. Prior to founding the Think Healthy Group, Dr. Wallace served as the Senior Director of Science Policy and Government Relations at the National Osteoporosis Foundation (NOF) and the Senior Director of Scientific
He speaks about: "Microbiome-adjusted nutrition for healthy ageing"
Programs at the National Bone Health Alliance (NBHA), a public-private partnership, managed and operated by the NOF. He has extensive experience in developing and implementing comprehensive and evidence-based legislative, policy, and regulatory programs in the fields of nutrition and food science. His academic research interests are in the area of nutritional interventions to promote health and prevent the onset of chronic disease. Dr. Wallace’s background includes a PhD and an MS in Food Science and Nutrition from The Ohio State University and a BS in Food Science and Technology from the University of Kentucky. In his free time, Dr. Wallace manages and operates a large food and nutrition blog, www.DrTaylorWallace.com, where he provides science-based nutrition, food safety, and food technology information to the general public and consumer media. Dr. Wallace has served on the Boards of Directors for the Institute of Food Technologists, Alliance for Food and Health, Feeding Tomorrow, and Phi Tau Sigma. He is a fellow of the American College of Nutrition and is the 2015 recipient of the Charles A. Regus Award, given by the American College of Nutrition for original research and innovation in the field of nutrition. Dr. Wallace is a Senior Fellow of the Center for Magnesium Education & Research, the Deputy Editor in Chief of the Journal of the American College of Nutrition, Editor in Chief of the Journal of Dietary Supplements, the editor of six academic textbooks, and an author of over 40 peer-reviewed manuscripts and book chapters. See why The Huffington Post called Dr. Taylor Wallace “the nation’s premier food and nutrition guru”.